07/10/2024 5:47 AM | C4 Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
06/11/2024 3:45 PM | C4 Therapeutics (Issuer) Cooper Ronald Harold Wilfred (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/11/2024 3:46 PM | C4 Therapeutics (Issuer) Cooper Ronald Harold Wilfred (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:41 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 6:10 AM | C4 Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024 6:07 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2024 7:52 AM | C4 Therapeutics (Filer)
| Form ARS | |
|
04/29/2024 7:03 AM | C4 Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024 7:04 AM | C4 Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024 3:16 PM | C4 Therapeutics (Issuer) Mossler Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 8:52 AM | C4 Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
03/08/2024 6:28 PM | Boyle Scott N (Reporting) C4 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:19 PM | C4 Therapeutics (Issuer) Siegel Jolie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:21 PM | Adams Kendra (Reporting) C4 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:24 PM | C4 Therapeutics (Issuer) Schick Kelly (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:26 PM | C4 Therapeutics (Issuer) Fisher Stewart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 12:11 PM | C4 Therapeutics (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
03/04/2024 6:05 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 8:01 AM | C4 Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024 6:15 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:20 AM | C4 Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 5:18 PM | C4 Therapeutics (Issuer) Hirsch Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 8:21 AM | C4 Therapeutics (Subject) Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
02/14/2024 6:35 AM | C4 Therapeutics (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/09/2024 12:04 PM | C4 Therapeutics (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/05/2024 9:24 AM | C4 Therapeutics (Subject) Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G | |
02/02/2024 8:34 AM | C4 Therapeutics (Subject) Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
01/12/2024 3:01 PM | Betta Investment Ltd. (0001990727) (Filed by) C4 Therapeutics (Subject)
| Form SC 13G | |
01/11/2024 6:05 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:15 PM | C4 Therapeutics (Subject) Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
01/03/2024 3:12 PM | C4 Therapeutics (Issuer) Dubin Glenn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 3:30 PM | C4 Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
12/22/2023 3:05 PM | C4 Therapeutics (Subject) COMMODORE CAPITAL LP (Filed by)
| Form SC 13G | |
12/12/2023 3:28 PM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2023 6:15 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/20/2023 3:21 PM | C4 Therapeutics (Issuer) Hughes Owen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 3:18 PM | C4 Therapeutics (Issuer) Hughes Owen (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/20/2023 6:05 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2023 6:31 AM | C4 Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023 6:18 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2023 3:26 PM | C4 Therapeutics (Issuer) GROGAN DONNA ROY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
How to build the ultimate dividend portfolio (Ad) There’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps?
PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE…
This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8553&Placement=NativeDisplay&Source=NativeDisplay) Click here and I’ll show you how to build the ultimate dividend portfolio. |
10/03/2023 3:27 PM | C4 Therapeutics (Issuer) Dubin Glenn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 3:28 PM | Anderson Kenneth Carl (Reporting) C4 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 6:20 PM | Adams Kendra (Reporting) C4 Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/19/2023 6:20 PM | C4 Therapeutics (Issuer) Mossler Mark (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/19/2023 6:21 PM | Adams Kendra (Reporting) C4 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 6:22 PM | C4 Therapeutics (Issuer) Siegel Jolie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 6:23 PM | Boyle Scott N (Reporting) C4 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 6:23 PM | C4 Therapeutics (Issuer) Fisher Stewart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 6:23 PM | C4 Therapeutics (Issuer) Schick Kelly (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 6:24 PM | C4 Therapeutics (Issuer) Hirsch Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 6:16 AM | C4 Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023 6:09 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |